SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-027953
Filing Date
2017-12-05
Accepted
2017-12-05 16:18:33
Documents
1
Period of Report
2017-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4761
  Complete submission text file 0000899243-17-027953.txt   7333
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Reporting) CIK: 0000901832 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33451 | Film No.: 171239878
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85
Business Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85 0044 (0) 20 7604 800
ASTRAZENECA AB (Reporting) CIK: 0000928966 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33451 | Film No.: 171239877

Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Issuer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1